Technical Analysis for AZN - Astrazeneca PLC

Grade Last Price % Change Price Change
grade D 38.505 1.65% 0.63
AZN closed up 0.91 percent on Tuesday, May 21, 2019, on 62 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical AZN trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 1.65%
Bollinger Band Squeeze Range Contraction 2.57%
Bollinger Band Squeeze Range Contraction 1.92%
Bollinger Band Squeeze Range Contraction 1.87%
Bollinger Band Squeeze Range Contraction 2.19%
Narrow Range Bar Range Contraction 2.19%
Bollinger Band Squeeze Range Contraction 1.81%
BB Squeeze Started Range Contraction 1.81%
Gapped Up Strength 1.81%
Narrow Range Bar Range Contraction 3.29%

Older signals for AZN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammation diseases worldwide. Its principal products include Atacand for hypertension and heart failure; Crestor for managing cholesterol levels; Seloken/Toprol-XL for hypertension, heart failure, and angina; Nexium for acid reflux; Synagis for RSV, a respiratory infection in infants; Seroquel IR for schizophrenia and bipolar disorders; and Seroquel XR for schizophrenia, bipolar disorder, and major depressive disorders. The company principal products also comprise Zoladex for prostate and breast cancer; Pulmicort for asthma and chronic obstructive pulmonary diseases; and Symbicort for asthma and chronic obstructive pulmonary diseases. In addition, it has 84 pipeline projects, which include 71 projects in various clinical phases of development. The company markets its products to primary care and specialist doctors through distributors or local representative offices. AstraZeneca PLC has collaboration agreements with Amgen, Inc. to develop and commercialize monoclonal antibodies; Ironwood Pharmaceuticals, Inc to co-develop and co-commercialize linaclotide in China; BIND Therapeutics, Inc. to develop and commercialize cancer nanomedicine; and WuXi AppTec to develop and commercialize MEDI5117, a biologic for autoimmune and inflammatory diseases. It also has a strategic alliance with Isis Pharmaceuticals, Inc. for the discovery and development of novel generation antisense therapeutics; and a strategic collaboration with FibroGen, Inc. to develop and commercialize FG-4592, a compound for the treatment of anemia associated with chronic kidney disease and end-stage renal disease. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in London, the United Kingdom.
Cancer Drugs Antibodies Monoclonal Antibodies Infection Breast Cancer Neuroscience Schizophrenia Asthma Chronic Kidney Disease Heart Failure Hypertension Anemia End Stage Renal Disease Psychoactive Drugs Astrazeneca Autoimmune And Inflammatory Diseases Pulmonology Bipolar Disorder Angina Chronic Obstructive Pulmonary Diseases Major Depressive Disorders Södertälje Municipality Bipolar Disorders Chronic Condition Ironwood Pharmaceuticals Respiratory Disease
Is AZN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 43.29
52 Week Low 34.38
Average Volume 5,436,511
200-Day Moving Average 38.987
50-Day Moving Average 39.8958
20-Day Moving Average 37.9735
10-Day Moving Average 37.82
Average True Range 0.5849
ADX 30.6
+DI 21.7735
-DI 31.4078
Chandelier Exit (Long, 3 ATRs ) 37.3953
Chandelier Exit (Short, 3 ATRs ) 38.587
Upper Bollinger Band 38.8675
Lower Bollinger Band 37.0795
Percent B (%b) 0.45
BandWidth 4.708547
MACD Line -0.5261
MACD Signal Line -0.6157
MACD Histogram 0.0896
Fundamentals Value
Market Cap 95.92 Billion
Num Shares 2.53 Billion
EPS 1.52
Price-to-Earnings (P/E) Ratio 24.92
Price-to-Sales 3.91
Price-to-Book 6.22
PEG Ratio 2.37
Dividend 0.90
Dividend Yield 2.38%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 38.39
Resistance 3 (R3) 38.36 38.15 38.31
Resistance 2 (R2) 38.15 38.02 38.17 38.28
Resistance 1 (R1) 38.02 37.94 38.09 38.05 38.25
Pivot Point 37.81 37.81 37.85 37.83 37.81
Support 1 (S1) 37.68 37.68 37.75 37.71 37.51
Support 2 (S2) 37.47 37.60 37.49 37.48
Support 3 (S3) 37.34 37.47 37.46
Support 4 (S4) 37.37